Marshall Wace North America’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$216K Buy
8,352
+1,856
+29% +$58.8K ﹤0.01% 1307
2021
Q2
$297K Buy
+6,496
New +$307K ﹤0.01% 1284
2021
Q1
Sell
-15,243
Closed -$469K 1854
2020
Q4
$469K Buy
+15,243
New +$483K ﹤0.01% 1100
2020
Q3
Sell
-43,958
Closed -$1.1M 1546
2020
Q2
$1.1M Buy
+43,958
New +$1.11M 0.01% 733

Other funds holding AMTI

Marshall Wace North America's AMTI Position: Q3 2021 in Review

Marshall Wace North America increased its Applied Molecular Transport Inc. Common Stock (AMTI) stake by 29% in Q3 2021, buying an estimated $58.8K and bringing the position to 8,352 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Marshall Wace North America first reported a position in AMTI in Q2 2020 and has held it in 4 quarters since. The position peaked at $1.1M in Q2 2020. 81 funds tracked by Wall St. Rank hold AMTI as of Q3 2021.

  • Marshall Wace North America held 8,352 shares of Applied Molecular Transport Inc. Common Stock worth $216K as of Q3 2021.
  • Marshall Wace North America bought 1,856 Applied Molecular Transport Inc. Common Stock shares in Q3 2021, an estimated $58.8K.
  • Applied Molecular Transport Inc. Common Stock made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1307 holding.
  • Marshall Wace North America first reported a position in Applied Molecular Transport Inc. Common Stock in Q2 2020 and has held it in 4 quarters since.
  • Marshall Wace North America's Applied Molecular Transport Inc. Common Stock position peaked at $1.1M in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.